ZANTE GREG

PrivateCIK: 1264949
Location

RICHMOND, CA

ZANTE GREG (Chief Financial Officer) sold 7.7% of their position (15K shares) of VIKING THERAPEUTICS, INC. on the open market

Open‑market sale worth $268.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderZANTE GREGCIK 1264949
IssuerVIKING THERAPEUTICS, INC.CIK 1607678
Officer· Chief Financial Officer
Since Jan 2021
+175.34K
Net shares
Net buyer
$1.38M
Total sold
1
Open market trades
0B · 1S
7
Total transactions
253.33K acquired · 77.99K disposed
Non-Derivative Transactions6

Common Stock, par value $0.00001 per share

Direct
A · Award

Shares

+28.33K

Price / share

Trade value

% of position

17.7%
1/3/2024
160.39K188.72K

Common Stock, par value $0.00001 per share

Direct
F · Tax Withholding

Shares

18.23K

Price / share

$17.40

Trade value

$317.25K

% of position

9.7%
1/3/2024
188.72K170.49K

Common Stock, par value $0.00001 per share

Direct
A · Award

Shares

+70K

Price / share

Trade value

% of position

41.1%
1/3/2024
170.49K240.49K

Common Stock, par value $0.00001 per share

Direct
F · Tax Withholding

Shares

30.89K

Price / share

$17.40

Trade value

$537.47K

% of position

12.8%
1/3/2024
240.49K209.60K

Common Stock, par value $0.00001 per share

Direct
F · Tax Withholding

Shares

13.87K

Price / share

$18.58

Trade value

$257.74K

% of position

6.6%
1/4/2024
209.60K195.73K

Common Stock, par value $0.00001 per share

Direct
S · Sale

Shares

15K

Price / share

$17.90

Trade value

$268.50K

% of position

7.7%
1/4/2024
195.73K180.73K
Total

Net shares

+20.34K

Net value

-$1.38M

Derivative Transactions1

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

155K shares

Shares

+155K

Strike price

17.40

Held after

155K

Exercisable

1/3/2024
ZANTE GREG — Insider Transaction (Form 4) Filed Jan 4, 2024 | Finecho